Shortage Watch Free FDA drug-shortage watch

← all medications

Montelukast Sodium Tablet, Chewable

Brand names: Singulair

Category: Pulmonary/Allergy

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Nov 17, 2025 · First posted: Nov 17, 2025 · 1 manufacturers, 1 listed presentations

As of Nov 17, 2025, the FDA lists Montelukast Sodium Tablet, Chewable as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Montelukast Sodium Tablet, Chewable is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)
NDC 78206-170-01
Organon Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Pulmonary/Allergy medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Montelukast Sodium Tablet, Chewable (FDA data as of Nov 17, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Montelukast Sodium Tablet, Chewable. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Montelukast Sodium Tablet, Chewable.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/montelukast-sodium-tablet-chewable.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).